Austria: ArchiMed earns 6x return on sale of EUROLyser to Antech Diagnostics

Trans-Atlantic private equity healthcare specialist ArchiMed has made the first exit from its MED II fund with the sale of Austria-based medical technology company EUROLyser to Antech Diagnostics, a provider of diagnostic and imaging solutions for the veterinary industry, in the US. Antech is part of Mars Veterinary Health.   Financial terms were not revealed….

You must be a HMI Subscriber to view this content.

Subscribe Now »